A new international consortium to facilitate Stem Cell-Based Therapy for Huntington’s disease

16 març, 2021

Anglès

Públic

Número de màster

4258

Descarregar

Notificar

The Stem Cells for Huntington’s Disease consortium (SC4HD) is a new network to guide the establishment of first-in-human advanced therapy medicinal product (ATMP) cell transplantation studies on Huntington’s Disease

More information is available on the websites: SC4HD (https://www.sc4hd.org/) and Creatio (https://www.ub.edu/creatio).

Docència i Recerca Ciències de la Salut Reportatges Medicina, infermeria, odontologia i podologia Universitat de Barcelona cèl·lules mare terapia medicinal

A new international consortium to facilitate Stem Cell-Based Therapy for Huntington’s disease

Vídeos relacionats